Acasti Pharma | ACST - Ebit

Aktienkurs
2.19
Täglich Wechseln
-0.06 -2.67%
Monatlich
-49.77%
Jährlich
-19.29%
Q2 Prognose
2.29




Ebit Veränderung Datum
Acasti Pharma USD -3.7M 1.13M 2024-12
Addus HomeCare USD 34.07M 8.2M 2026-03
Amarin USD -2.26M 564K 2025-12
Cassava Sciences USD -13.55M 1.69M 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Option Care Health USD 72.54M 18.96M 2026-03
Organigram Holdings CAD -20.13M 7.92M 2025-12
Tilray USD -20.01M 9.34M 2025-09